Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings
Stanford University
Summary
The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
Description
Specifically, we aim to measure differences in drug liking with a VAS (0 - 100) questionnaire. Additionally, we will monitor neural activity recording a frontal electroencephalogram (EEG) to detect changes in brain signals associated with opioid drug effects. By comparing behavioral and neurophysiological data across treatment and control groups, this study seeks to explore the therapeutic potential of this medication.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * American Society of Anesthesiologists (ASA) physical status classification of I, II or III * Candidates who are expected to receive fentanyl up to 3 mcg/kg IBW for their scheduled for surgery or procedure Exclusion Criteria: * Craniofacial abnormalities * Known or suspected difficult intubation or mask ventilation * Known or suspected need for rapid sequence induction and intubation * Allergies or hypersensitivities to amisulpride or fentanyl * Clinically significant pulmonary disease, such as chronic obstructive lung disease requiring long-term oxygen therapy, or othe…
Interventions
- DrugAmisulpride
Medication administered as a single intravenous dose.
- DrugPlacebo
Matching Placebo given by single intravenous (IV) administration.
Location
- Stanford HospitalPalo Alto, California